InveniAI Announces Launch of AlphaMeld Corporation and Major Milestone Updates to Reflect Cutting-Edge Innovation in AI-Driven Drug Discovery

Quick Summary:

Transforming the landscape of drug discovery with next-gen capabilities in obesity research, small molecule and antibody design, antibody-drug conjugate development, and interactive AIGUILFORD, Conn., Jan.13, 2025 (GLOBE NEWSWIRE) -- InveniAI LLC, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutionize drug discovery and development, today announced several transformative milestones as part of its continued commitment to revolutionizing the drug development process.

About AlphaMeld CorporationHeadquartered in Guilford, CT, AlphaMeld Corporation (a wholly owned subsidiary of InveniAI LLC) stands as a global frontrunner in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools, catalyzing innovation throughout drug discovery and development.

To mark this next chapter of innovation, the company has launched a wholly owned subsidiary, AlphaMeld Corporation®, a name that reflects its mission to meld advanced artificial intelligence (AI), machine learning (ML), and generative AI with domain expertise to identify "alpha signals” of innovation for the development of impactful therapeutic solutions.

Read Quick SummarySave Time

or

Article Details

Author / Journalist: InveniAI LLC

Category: Technology

Markets: China

Topics: Design Artificial Alphameld Development Company Discovery Drug Novel Therapeutic Intelligence Corporation

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-01-13 @ 15:00:00 (1 weeks ago)

News Timezone: GMT +8:00

News Source URL: globenewswire.com

Language: English

Article Length: 528 words

Reading Time: 3 minutes read

Sentences: 16 lines

Sentence Length: 33 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © GlobeNewswire

News ID: 25108224

View Article Analysis

About GlobeNewswire

Main Topics: Technology

Official Website: globenewswire.com

Update Frequency: 34 posts per day

Year Established: 1998

Headquarters: China

News Last Updated: 9 hours ago

Coverage Areas: China

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #116

Publisher Details

Frequently Asked Questions